Gene expression in the etiology of schizophrenia.

Gene expression represents a fundamental interface between genes and environment in the development and ongoing plasticity of the human brain. Individual differences in gene expression are likely to underpin much of human diversity, including psychiatric illness. In the past decade, the development of microarray and proteomic technology has enabled global description of gene expression in schizophrenia. However, it is difficult on the basis of gene expression assays alone to distinguish between those changes that constitute primary etiology and those that reflect secondary pathology, compensatory mechanisms, or confounding influences. In this respect, tests of genetic association with schizophrenia will be instructive because changes in gene expression that result from gene variants that are associated with the disorder are likely to be of primary etiological significance. However, regulatory polymorphism is extremely difficult to recognize on the basis of sequence interrogation alone. Functional assays at the messenger RNA and/or protein level will be essential in elucidating the molecular mechanisms underlying genetic association with schizophrenia and are likely to become increasingly important in the identification of regulatory variants with which to test for association with the disorder and related traits. Once established, etiologically relevant changes in gene expression can be recapitulated in model systems in order to elucidate the molecular and physiological pathways that may ultimately give rise to the condition.

[1]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[2]  D. Stephan,et al.  A survey of genetic human cortical gene expression , 2007, Nature Genetics.

[3]  T. Hudson,et al.  Mapping common regulatory variants to human haplotypes. , 2005, Human molecular genetics.

[4]  P. Seeman,et al.  Brain receptors for antipsychotic drugs and dopamine: direct binding assays. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Daniel R Weinberger,et al.  Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. , 2004, Archives of general psychiatry.

[6]  Daniel R Weinberger,et al.  Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study , 2002, Schizophrenia Research.

[7]  A. LaMantia,et al.  When half is not enough: gene expression and dosage in the 22q11 deletion syndrome. , 2006, Gene expression.

[8]  R Hashimoto,et al.  Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia , 2004, Molecular Psychiatry.

[9]  Martin S. Taylor,et al.  Disruption of two novel genes by a translocation co-segregating with schizophrenia. , 2000, Human molecular genetics.

[10]  R. Straub,et al.  Evidence That the BLOC-1 Protein Dysbindin Modulates Dopamine D2 Receptor Internalization and Signaling But Not D1 Internalization , 2007, The Journal of Neuroscience.

[11]  Raquel E Gur,et al.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. , 2004, The Journal of clinical investigation.

[12]  Takahisa Taguchi,et al.  Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. , 2004, Human molecular genetics.

[13]  Paul J. Harrison,et al.  Molecular Cloning of a Brain-specific, Developmentally Regulated Neuregulin 1 (NRG1) Isoform and Identification of a Functional Promoter Variant Associated with Schizophrenia*♦ , 2007, Journal of Biological Chemistry.

[14]  M. Owen,et al.  An update on the genetics of schizophrenia , 2006, Current opinion in psychiatry.

[15]  Marquis P Vawter,et al.  Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree , 2004, Schizophrenia Research.

[16]  Kari Stefansson,et al.  Neuregulin1 (NRG1) Signaling through Fyn Modulates NMDA Receptor Phosphorylation: Differential Synaptic Function in NRG1+/− Knock-Outs Compared with Wild-Type Mice , 2007, The Journal of Neuroscience.

[17]  Daniel R Weinberger,et al.  Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. , 2006, Human molecular genetics.

[18]  R. Place,et al.  Small dsRNAs induce transcriptional activation in human cells , 2006, Proceedings of the National Academy of Sciences.

[19]  Douglas L Falls,et al.  Neuregulins: functions, forms, and signaling strategies. , 2003, Experimental cell research.

[20]  A. Sandelin,et al.  Applied bioinformatics for the identification of regulatory elements , 2004, Nature Reviews Genetics.

[21]  R. Straub,et al.  Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients , 2008, Schizophrenia Research.

[22]  N. Craddock,et al.  Cis- and trans- loci influence expression of the schizophrenia susceptibility gene DTNBP1. , 2008, Human molecular genetics.

[23]  R. Scott,et al.  Altered expression of regulator of G-protein signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia , 2007, Schizophrenia Research.

[24]  N. Schork,et al.  Endophenotyping schizophrenia. , 2007, The American journal of psychiatry.

[25]  Paul J. Harrison,et al.  Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs , 2000, Molecular Psychiatry.

[26]  M. O’Donovan,et al.  Investigating cis-acting regulatory variation using assays of relative allelic expression. , 2006, Psychiatric genetics.

[27]  L. Liang,et al.  A genome-wide association study of global gene expression , 2007, Nature Genetics.

[28]  Xin Duan,et al.  Disrupted-In-Schizophrenia 1 Regulates Integration of Newly Generated Neurons in the Adult Brain , 2007, Cell.

[29]  J. Waddington,et al.  Phenotypic characterization of spatial cognition and social behavior in mice with ‘knockout’ of the schizophrenia risk gene neuregulin 1 , 2007, Neuroscience.

[30]  J. Beckmann,et al.  A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.

[31]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[32]  R. Yolken,et al.  Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder , 2000, Molecular Psychiatry.

[33]  R. Murray,et al.  Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. , 1999, Archives of general psychiatry.

[34]  Joshua T. Burdick,et al.  Mapping determinants of human gene expression by regional and genome-wide association , 2005, Nature.

[35]  J. Pierri,et al.  Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia , 2002, The Journal of Neuroscience.

[36]  Dominic P. Kwiatkowski,et al.  In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading , 2003, Nature Genetics.

[37]  D. Clair,et al.  Association within a family of a balanced autosomal translocation with major mental illness , 1990, The Lancet.

[38]  Satoshi Kida,et al.  Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans , 2007, Proceedings of the National Academy of Sciences.

[39]  K. Iwamoto,et al.  Gene Expression Profiling in Schizophrenia and Related Mental Disorders , 2006, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[40]  A. Kakita,et al.  Prefrontal Abnormality of Schizophrenia Revealed by DNA Microarray: Impact on Glial and Neurotrophic Gene Expression , 2004, Annals of the New York Academy of Sciences.

[41]  P. Seeman,et al.  Schizophrenia: elevated mRNA for dopamine D2(Longer) receptors in frontal cortex. , 2001, Brain research. Molecular brain research.

[42]  Christopher A. Ross,et al.  A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development , 2005, Nature Cell Biology.

[43]  R. Yolken,et al.  Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress , 2004, Molecular Psychiatry.

[44]  Andrew L. Lemire,et al.  Deficient Hippocampal Neuron Expression of Proteasome, Ubiquitin, and Mitochondrial Genes in Multiple Schizophrenia Cohorts , 2005, Biological Psychiatry.

[45]  Jennifer E. Chubb,et al.  The DISC locus in psychiatric illness , 2008, Molecular Psychiatry.

[46]  R. Scott,et al.  Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia , 2006, Schizophrenia Research.

[47]  T. Crow,et al.  3H-flupenthixol binding in post-mortem brains of schizophrenics: Evidence for a selective increase in dopamine D2 receptors , 2004, Psychopharmacology.

[48]  P. Sham,et al.  The future of association studies: gene-based analysis and replication. , 2004, American journal of human genetics.

[49]  D. Lancet,et al.  Is the G72/G30 locus associated with schizophrenia? single nucleotide polymorphisms, haplotypes, and gene expression analysis , 2004, Biological Psychiatry.

[50]  J. Trojanowski,et al.  Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. , 2002, Archives of general psychiatry.

[51]  E. Gershon,et al.  Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia , 2002, Molecular Psychiatry.

[52]  P. Levitt,et al.  Critical Appraisal of DNA Microarrays in Psychiatric Genomics , 2006, Biological Psychiatry.

[53]  Ellen M Wijsman,et al.  Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[54]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[55]  K. Kaibuchi,et al.  DISC1 Regulates Neurotrophin-Induced Axon Elongation via Interaction with Grb2 , 2007, The Journal of Neuroscience.

[56]  Michael C O'Donovan,et al.  Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. , 2005, Human molecular genetics.

[57]  Michael C O'Donovan,et al.  A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. , 2003, American journal of human genetics.

[58]  D. Rujescu,et al.  Strong evidence that GNB1L is associated with schizophrenia. , 2008, Human molecular genetics.

[59]  E. Kandel,et al.  Transient and Selective Overexpression of Dopamine D2 Receptors in the Striatum Causes Persistent Abnormalities in Prefrontal Cortex Functioning , 2006, Neuron.

[60]  Jennifer E. Chubb,et al.  DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling , 2005, Science.

[61]  S. Cordwell,et al.  A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia , 2006, Molecular Psychiatry.

[62]  M. Owen,et al.  DISC1 mRNA expression is not influenced by common Cis‐acting regulatory polymorphisms or imprinting , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[63]  I. Gottesman Schizophrenia Genesis: The Origins of Madness , 1990 .

[64]  Daniel R. Weinberger,et al.  Neuregulin 1 Transcripts Are Differentially Expressed in Schizophrenia and Regulated by 5′ SNPs Associated With the Disease , 2006 .

[65]  C. Tamminga,et al.  Regional alterations in RGS4 protein in schizophrenia , 2006, Synapse.

[66]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[67]  M. Owen,et al.  High rates of schizophrenia in adults with velo-cardio-facial syndrome (VCFS) , 1999, Schizophrenia Research.

[68]  L. Southam,et al.  Extreme context specificity in differential allelic expression. , 2007, Human molecular genetics.

[69]  Kyla Pennington,et al.  Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease‐associated changes , 2006, Proteomics.

[70]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[71]  Peter B. Jones,et al.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.

[72]  R. Tjian,et al.  Transcription regulation and animal diversity , 2003, Nature.

[73]  Maria Karayiorgou,et al.  Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia , 2004, Nature Genetics.

[74]  D. Goldstein,et al.  In vitro assays fail to predict in vivo effects of regulatory polymorphisms. , 2007, Human molecular genetics.

[75]  M V Ovanesov,et al.  Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia , 2008, Molecular Psychiatry.